17Beta-estradiol Stimulates Glucose Uptake Through Estrogen Receptor and AMP-activated Protein Kinase Activation in C2C12 Myotubes
10.7570/kjo.2016.25.4.190
- Author:
Ki Ho LEE
1
;
Kyung Jin JO
;
Ju Young KIM
;
Haing Woon BAIK
;
Seong Kyu LEE
Author Information
1. Department of Biochemistry-Molecular Biology, Eulji University School of Medicine, Daejeon, Korea. lskendo@hanmail.net
- Publication Type:Original Article
- Keywords:
17Beta-estradiol;
Estrogen receptor;
AMP-activated protein kinase;
Glucose uptake
- MeSH:
AMP-Activated Protein Kinases;
Carnitine O-Palmitoyltransferase;
Energy Metabolism;
Estrogens;
Glucose Transport Proteins, Facilitative;
Glucose;
Muscle Fibers, Skeletal;
Peroxisomes;
Phosphorylation;
Rodentia
- From:Korean Journal of Obesity
2016;25(4):190-196
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Previous studies have shown that 17beta-estradiol activates AMP-activated protein kinase (AMPK) in rodent muscle and C2C12 myotubes and that acute 17beta-estradiol treatment rapidly increases AMPK phosphorylation possibly through non-genomic effects but does not stimulate glucose uptake. Here, we investigated whether 24-hour 17beta-estradiol treatment stimulated glucose uptake and regulated the expression of genes associated with glucose and energy metabolism through the genomic effects of estrogen receptor (ER) in C2C12 myotubes. METHODS: C2C12 myotubes were treated with 17beta-estradiol for 24 hours, and activation of AMPK, uptake of glucose, and expression of genes encoding peroxisome proliferator-activated receptor γ coactivator 1α, carnitine palmitoyltransferase 1β, uncoupling protein 2, and glucose transporter 4 were examined. Furthermore, we investigated whether AMPK inhibitor (compound C) or estrogen receptor antagonist (ICI182.780) treatment reversed 17beta-estradiol-induced changes. RESULTS: We found that 24-hour treatment of C2C12 myotubes with 17beta-estradiol stimulated AMPK activation and glucose uptake and regulated the expression of genes associated with glucose and energy metabolism. Treatment of C2C12 myotubes with the estrogen receptor antagonist (ICI182.780) reversed 17beta-estradiol-induced AMPK activation, glucose uptake, and changes in the expression of target genes. Furthermore, treatment with the AMPK inhibitor (compound C) reversed 17beta-estradiol-induced glucose uptake and changes in the expression of target genes. CONCLUSION: Our results suggest that 17beta-estradiol stimulates AMPK activation and glucose uptake and regulates the expression of genes associated with glucose and energy metabolism in C2C12 myotubes through the genomic effects of ER.
